© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 1, 39-45,
January 3, 2001
© 2001 Oxford University Press
REPORT |
Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells
Affiliations of authors: B.-S. Herbert, A. C. Wright, C. M. Passons, W. E. Wright, J. W. Shay, Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas; I. U. Ali, L. Kopelovich, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD.
Correspondence to: Jerry W. Shay, Ph.D., Department of Cell Biology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390–9039 (e-mail: Jerry.Shay{at}UTSouthwestern.edu).
Background: Activation of telomerase is an early event in the development of breast and other cancers that may lead to cell immortalization, a critical and rate-limiting step in cancer progression. Breast epithelial cells from women with Li–Fraumeni syndrome (LFS) immortalize spontaneously and reproducibly in culture. We, therefore, tested whether immortalization of these cells could be prevented by treating them with chemopreventive agents and by inhibiting telomerase activity. Methods: Noncancerous, preimmortal breast epithelial cells derived from a patient with LFS were treated for 3 months with nontoxic concentrations of the chemopreventive agents oltipraz, difluoromethylornithine, tamoxifen, and retinoic acid or with two different telomerase inhibitors. The frequency of spontaneous immortalization of LFS-derived cells was estimated by an approach based on fluctuation analyses. Statistical analyses were two-sided. Results: The frequency of spontaneous immortalization events of LFS-derived breast epithelial cells was reduced by long-term treatment with retinoic acid (P<.001) or tamoxifen (P<.05) compared with solvent-treated cells. The frequency of immortalization was also reduced by treating LFS-derived cells with an antitelomerase antisense oligonucleotide (P<.001) or by inducing the cells to express a dominant negative mutant of telomerase (P<.025) compared with cells treated with a control oligonucleotide or with empty vector, respectively. Conclusions: Treatment of preimmortal LFS breast epithelial cells with chemopreventive and antitelomerase agents decreased the frequency of spontaneous immortalization in vitro. These studies validate the application of a new cell culture model system to screen the effects of novel chemopreventive agents by use of cell immortalization as an end point. The results also suggest that the telomerase ribonucleoprotein complex may be an important molecular target for breast cancer prevention.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Liu, F. Innocenti, M. J. Ratain, N. Kato, Y. Wang, and M. Omata Linkage Disequilibrium across the UGT1A Locus Should Not Be Ignored in Association Studies of Cancer Susceptibility Clin. Cancer Res., February 1, 2005; 11(3): 1348 - 1349. [Full Text] [PDF]
|
|
|
|
 |
|
 O. E. Bechter, Y. Zou, W. Walker, W. E. Wright, and J. W. Shay Telomeric Recombination in Mismatch Repair Deficient Human Colon Cancer Cells after Telomerase Inhibition Cancer Res., May 15, 2004; 64(10): 3444 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kraemer, S. Fuessel, U. Schmidt, M. Kotzsch, B. Schwenzer, M. P. Wirth, and A. Meye Antisense-mediated hTERT Inhibition Specifically Reduces the Growth of Human Bladder Cancer Cells Clin. Cancer Res., September 1, 2003; 9(10): 3794 - 3800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-S. Herbert, V. P. Pearce, L. S. Hynan, D. M. LaRue, W. E. Wright, L. Kopelovich, and J. W. Shay A Peroxisome Proliferator-activated Receptor-{gamma} Agonist and the p53 Rescue Drug CP-31398 Inhibit the Spontaneous Immortalization of Breast Epithelial Cells Cancer Res., April 15, 2003; 63(8): 1914 - 1919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Naasani, F. Oh-hashi, T. Oh-hara, W. Y. Feng, J. Johnston, K. Chan, and T. Tsuruo Blocking Telomerase by Dietary Polyphenols Is a Major Mechanism for Limiting the Growth of Human Cancer Cells in Vitro and in Vivo Cancer Res., February 15, 2003; 63(4): 824 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Gowan, J. R. Harrison, L. Patterson, M. Valenti, M. A. Read, S. Neidle, and L. R. Kelland A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity Mol. Pharmacol., May 1, 2002; 61(5): 1154 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zheng, J.-L. Fang, and P. Lazarus Glucuronidation: An Important Mechanism for Detoxification of Benzo[a]Pyrene Metabolites in Aerodigestive Tract Tissues Drug Metab. Dispos., April 1, 2002; 30(4): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Fang, F. A. Beland, D. R. Doerge, D. Wiener, C. Guillemette, M. M. Marques, and P. Lazarus Characterization of Benzo(a)pyrene-trans-7,8-dihydrodiol Glucuronidation by Human Tissue Microsomes and Overexpressed UDP-glucuronosyltransferase Enzymes Cancer Res., April 1, 2002; 62(7): 1978 - 1986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Ruggeri, C. Robinson, T. Angeles, J. Wilkinson IV, and M. L. Clapper The Chemopreventive Agent Oltipraz Possesses Potent Antiangiogenic Activity in Vitro, ex Vivo, and in Vivo and Inhibits Tumor Xenograft Growth Clin. Cancer Res., January 1, 2002; 8(1): 267 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Frosina Counteracting spontaneous transformation via overexpression of rate-limiting DNA base excision repair enzymes Carcinogenesis, September 1, 2001; 22(9): 1335 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Soria, C. Moon, L. Wang, W. N. Hittelman, S. J. Jang, S.-Y. Sun, J. J. Lee, D. Liu, J. M. Kurie, R. C. Morice, et al. Effects of N-(4-Hydroxyphenyl)retinamide on hTERT Expression in the Bronchial Epithelium of Cigarette Smokers J Natl Cancer Inst, August 15, 2001; 93(16): 1257 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Shay, Y. Zou, E. Hiyama, and W. E. Wright Telomerase and cancer Hum. Mol. Genet., April 1, 2001; 10(7): 677 - 685. [Abstract] [Full Text] [PDF]
|
|